Crystalvue Medical Corporation

NT$72.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6527Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 8.08%
Div yield 4.02%
ROE 14.88%
Medical Instruments & Supplies
Beta (5Y) 0.71
PE TTM 12.16
TSR TTM (7.85%)
Mkt cap NT$1.827B
ROIC 14.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$69
(4.62%)
(93.64%)
Buy 12|5|3|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.85
0.85
0.82
0.81
11.77%
0.68%
(4.08%)
(5.28%)
RevenueNT$M
143.6
145.5
153.2
162.1
15.43%
11.93%
11.92%
15.60%
Peers (US$55.19M)
Cap (US$)
PE
50.96M
9.188x
Capital
TTM
5Y
10Y
Leveragex
1.350
(0.073)
(0.093)
EBIT/Intx
15.96
0.702
0.643
Own earn%
67.90
(10.05)
(10.09)
Sh yield%
22.72
49.15
52.56
Owners
Insiders/Inst%
12.48
50.39
Short interest%
1.40
SBC / revenue%
2.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–8
$1 testx
−0.1
Incr. ROIC%
4